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A B S T R A C T
Due to its ubiquity and versatility in the human body, collagen is an ideal base material for tissue-engineering
constructs. Chemical crosslinking treatments allow precise control of the biochemical and mechanical properties
through macromolecular modifications to the structure of collagen. In this work, three key facets regarding the
collagen crosslinking process are explored. Firstly, a comparison is drawn between the carbodiimide-succinimide
(EDC-NHS) system and two emerging crosslinkers utilising alternate chemistries: genipin and tissue transglu-
taminase (TG2). By characterising the chemical changes upon treatment, the effect of EDC-NHS, genipin and
TG2 crosslinking mechanisms on the chemical structure of collagen, and thus the mechanical properties con-
ferred to the substrate is explored. Secondly, the relative importance of mechanical and biochemical cues on
cellular phenomena are investigated, including cell viability, integrin-specific attachment, spreading and pro-
liferation. Here, we observe that for human dermal fibroblasts, long-term, stable proliferation is preconditioned
by the availability of suitable binding sites, irrespective of the substrate modulus post-crosslinking. Finally, as
seen in the graphical abstract we show that by choosing the appropriate crosslinker chemistries, a materials
selection map can be drawn for collagen films, encompassing both a range of tensile modulus and fibroblast
proliferation which can be modified independently. Thus, in addition to a range of parameters that can be
modified in collagen constructs, we demonstrate a route to obtaining tunable bioactivity and mechanics in
collagen constructs is uncovered, that is exclusively driven by the crosslinking process.
1. Introduction
Collagen-I, a primary protein component of the extracellular matrix
(ECM) has been widely employed as a base material for tissue en-
gineering constructs with the aim of providing a similar chemical en-
vironment to the one experienced in vivo [1–3]. The ubiquity of col-
lagen in connective tissue has promoted its use in medical devices
tailored for a broad range of applications. These include injectable
hydrogels for cartilage repair [4] and dense fibrillar matrices prepared
from neutralised acid-soluble collagen for dermal wound healing [5],
collagen membranes as a periodontal barrier [6] and freeze-dried
porous scaffolds fabricated from insoluble microfibrillar collagen for ex-
vivo platelet production in flow bioreactors [7]. Though they vary in
the type, source or solubility of collagen, these constructs can be
crosslinked to tune their mechanical properties to match the loads
experienced in-service at the host tissue site. Collagen-I fibres naturally
possess amide crosslinks along their polypeptide chains, providing
mechanical [8–10] and proteolytic [11–13] stability to the fibres. To
mimic these natural crosslinks, amine-based crosslinkers [14–18] have
been considered to be ideal candidates to crosslink processed collagen
in tissue engineering constructs.
Collagen is recognised by a range of cell receptors including in-
tegrins, discoidin domain receptors, LAIR-1, mannose receptors and
glycoprotein VI, of which integrin receptors comprise the primary
group [19]. These receptors are heterodimers composed of an and
subunit [20]. Collagen specifically binds to the metal ion-dependent
adhesion site (the MIDAS motif) in the integrins. This metal ion, often
magnesium, is stabilised by glutamates (E), and results in a specificity
for GXOGER motifs expressed by the tropocollagen molecules within
the collagen fibres [19].
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One of the most common crosslinkers for collagen includes a com-
bination of 1-ethyl-3(3-dimethylaminopropyl-carbodiimide hydro-
chloride (EDC) with N-hydroxysuccinimide (NHS), with early work by
Olde Damink et al. [15] establishing industry standards for the cross-
linker ratios to be used with collagen. However, despite its popularity,
EDC-NHS has been shown to produce low levels of integrin-specific cell
binding at higher crosslinking conditions [21]. This phenomenon has
been purported to be caused by the interaction between EDC and the
carboxylate anions (E) within the MIDAS motifs in collagen
(Supplementary Fig. 1a). It has also been suggested that lost cell ad-
hesion can be subsequently restored through the artificial introduction
of the peptide sequence post-crosslinking [22].
Genipin and tissue transglutaminase (TG2) present two alternative
amine based crosslinkers that have been widely used with tissue en-
gineering constructs: genipin is commonly used with chitosan [23]
whereas TG2 has found use with soluble collagen [17] and other pro-
teins of the extracellular matrix including thrombin, fibrin and gelatin
[24]. Genipin crosslinks collagen via an imide crosslinking mechanism
(Supplementary Fig. 1b), whereby primary lysines in the collagen
backbone are bound to genipin precursor [25]. Genipin therefore does
not crosslink via the glutamic acids (E) in collagen, and leaves the
GXOGER motifs unaffected during the crosslinking process.
Transglutaminases are a family of transferases responsible for
crosslinking of skin, hair and blood clots in vivo and have shown ex-
ceptional cellular responses, including increased attachment of human
osteoblasts to collagen scaffolds upon crosslinking [26]. Transgluta-
minases bind to glutamines in the polypeptide chain, activating them
for further reactions (Supplementary Fig. 1c) [27]. In the presence of
water, this results in the conversion of the glutamine to a glutamate,
whereas in the presence of a suitable amine, an amide bond is formed at
the site of the activated glutamine [27]. Thus TG2 can either serve to
act as an amide crosslinker that does not utilise pre-existing aspartic or
glutamic acids (E and D) in the formation of crosslinks, or conversely
could help re-introduce glutamates (E) in the substrate, thus increasing
the number of MIDAS motifs on the substrate.
However, treating collagen with any crosslinker can alter the
structure of collagen I across various length scales. Additionally, the
wide variety of formats adopted by collagen-based medical devices
gives rise to a range of two–three dimensional architectures that can be
fabricated, which can also contribute to differences in cellular beha-
viour. The concomitant alteration of various biochemical and structural
cues upon crosslinking creates great difficulty in attributing cell re-
sponses to a single property of the substrate. Two dimensional films of
insoluble microfibrillar collagen-I can be used in place of neutralised
collagen monolayer coatings or three-dimensional scaffolds as a sur-
rogate in the assessment of cellular response without introducing the
complexity of microarchitecture, macroscopic swelling and fluid flow
that can be varied in three dimensional architecture [28]. Using human
dermal fibroblasts (HDFs) as a cheap and robust cell line expressing a
stable phenotype and a range of integrins that can bind to collagen [29]
also allows for the comparison of integrin-specific cell attachment to
longer term cell proliferation and viability. Through rigorous con-
sideration of the mechanochemical influence of the crosslinkers on
collagen as well as the cellular interactions with the treated films,
further insights are provided here to uncouple the effects of mechanical
and chemical cues on cellular response.
2. Materials and Methods
2.1. Film fabrication
Type I dermal microfibrillar bovine collagen (18–36 month Bos
Taurus cattle, 38.8 mmol amide N/100g, 76.1 ± 1.6% total protein
content not including Cys and Trp). A 0.5% suspension of collagen-I
was prepared in 0.05 M acetic acid solution (Alfa Aesar) and left to
swell overnight at 4 °C. Suspensions were homogenised at 22,000 rpm
for 4 min in total using a commercial blender (Waring model 8011 EG).
The resulting suspension was degassed under vacuum to remove any air
bubbles. Films were prepared by adding 400 l of suspension to a 24 well
plate (Corning) or 200 ml to a 48 well plate (Corning). Films were left
to dry for 48 h before crosslinking.
2.2. Crosslinking
2.2.1. EDC-NHS
A crosslinking solution of 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide hydrochloride (EDC, Sigma-Aldrich) and N-hydro-
xysuccinimide (NHS, Sigma-Aldrich) was prepared using a 5:2:1 M ratio
for EDC: NHS:Collagen, hereafter referred to as the ‘100% concentra-
tion’. For every 1 g of collagen, the 100% concentration standard of
crosslinking solution consisted of 1.15 g EDC and 0.276 g NHS dis-
solved in 75% ethanol. Diluted crosslinking solutions were prepared at
a molar ratio of 5:2:2 and 5:2:10 EDC:NHS:Collagen, hereby referred to
as the ‘50%’ and ‘10%’ crosslinking concentrations for EDC-NHS. Films
were immersed in 100%, 50% and 10% crosslinking solution for 2 h at
ambient temperature.
2.2.2. Genipin
Using a mass for mass equivalence for genipin to PBS adapted from
the protocol by Zhang et al. [30], for every 1 g of collagen the 100%
concentration standard of crosslinking solution consisted of 0.7812 g of
genipin (Challenge Bioproducts 160919) dissolved in PBS (Sigma Al-
drich). Crosslinking solutions prepared at a mass ratio of 1.5624 g of
genipin per gram of collagen are referred to as the ‘200%’ and mass
ratio of 0.46872 g genipin per gram of collagen referred to as the ‘60%’
crosslinking concentrations for genipin. Samples were immersed in
60%, 100% and 200% crosslinking solution for 24 h at ambient tem-
perature.
2.2.3. Tissue transglutaminase 2
Using a mass for mass equivalence for TG2 (from guinea pig liver,
99% purity, 4.8 units/mg protein, Sigma Aldrich T5398) and Tris buffer
in the protocol adopted by Chau et al. [26], for every 1 g of collagen the
100% concentration standard of crosslinking solution consisted of 1 mg
of TG2 (Sigma Aldrich) dissolved in Tris Buffer pH 7.5 (Sigma Aldrich)
and 5 mM CaCl2 (Sigma Aldrich). Solutions prepared with 0.4 mg of
TG2 per gram of collagen and 2.0 mg of TG2 per gram of collagen are
referred to as the ‘40%’ and ‘200%’ crosslinking concentrations for TG2.
Samples were immersed in 40%, 100% and 200% crosslinking solutions
for 24 h at 37 °C.
All crosslinked films were washed with distilled water (10 s × 4)
followed by soaking in distilled water for longer intervals (15 min × 4).
Films were left to dry for 48 h before use.
2.3. Free amine ninhydrin assay
The free amine content of collagen films was determined using the
ninhydrin assay. A solution of ninhydrin was prepared by adding 0.25 g
of ninhydrin to 5 ml of ethanol per mg of collagen. Ninhydrin solution
was added to each well of collagen crosslinked films, then plates were
sealed with Parafilm and heated to 80 °C for 20 min. Plates were cooled
to ambient room temperature and eluted with 50% isopropanol
(1.25 ml isopropanol per 1 ml of ninhydrin solution). 200 l of the re-
sultant Ruhemann's purple dye was transferred to a 96 well plate and
the absorbance was read at 570 nm using a using a SPECTROstar Nano
plate reader (BMG LABTECH Ltd, Aylesbury, UK). A standard curve was
prepared using glycine (Sigma-Aldrich) and the linear region of ab-
sorbance with concentration was used to convert sample absorbances to
amine content. The degree of crosslinking was then determined ac-
cording to the formula:













Fourier-transform Infrared (FTIR) spectra of the free standing col-
lagen treated and untreated films were obtained in ATR mode, with a
wavenumber resolution of 4 −cm 1. The amide I peaks were subsequently
deconvolved, and the proportion of the total amide peak area occupied
by the triple helical peak was then obtained through the Peak Analyzer
tool in Origin (Maximum Constant Baseline Subtraction, Hidden peak
finding by second derivative). Data are presented as the mean percen-
tage of the area occupied by the triple helical component and -helical
components ± standard deviation of three replicates.
2.5. Tensile testing
Collagen films were cast and cut into 35 mm × 15 mm rectangular
strips, then crosslinked with EDC-NHS, genipin and TG2. The dimen-
sions of each film were measured post crosslinking, and an average
thickness for each film was obtained across 10 measurements from
optical micrographs. Mechanical testing of the films was then carried
out using a 5 N load cell in a hydrated chamber in Hounsfield tensile
tester (Tinius Olsen) at a constant extension rate of 5 mm −min 1. All
samples were stretched until failure or yielding and data were used to
plot a stress–strain curve. The tensile modulus (E) was defined as the
gradient at the initial linear portion of the stress-strain. Results are
reported as means± standard deviations of an experiment performed in
triplicate.
2.6. Cell culture
Human dermal fibroblasts were purchased from the European
Collection of Animal Cell Cultures (Porton Down, UK) and maintained
in a humidified incubator at 37 °C with 5% CO2. Cells were cultured in
Dulbecco's Modified Eagle Medium (DMEM) (Sigma-Aldrich) with 10%
foetal bovine serum and 1% streptavidin/penicillin. When needed, cells
were detached from cell culture flasks with 0.05% Trypsin/0.02%
EDTA (Sigma-Aldrich) and re-suspended in serum free DMEM.
2.7. LDH cell attachment assay
Crosslinked films prepared in 48 well plates (Corning) were pre-
blocked with 200 l 5% (w/v) bovine serum albumin (Sigma-Aldrich) for
1 h at ambient room temperature. Wells were washed with 200 l of PBS
(Invitrogen) and 200 l of human dermal fibroblasts (1× 105 cells/ml)
suspended in serum free DMEM media containing either 5 mMMgCl2 or
5 mM EDTA were added for 1 h at 37 °C. Plates were washed three
times with PBS to remove loosely bound cells (200 l) and permeabilised
with 100 l per well of 2% Triton-X lysis buffer (in water) for 90 min at
ambient room temperature. Subsequently, 100 l of lactate dehy-
drogenase (LDH) substrate (Cytotoxicity detection kit, Roche), prepared
according to the manufacturer's instructions was added per well for
20 min and the absorbance read at 490 nm using a SPECTROstar Nano
plate reader (BMG LABTECH Ltd, Aylesbury, UK). Results are reported
as means ± standard deviations of three independent experiments
performed in triplicate.
2.8. MTS cell proliferation assay
Crosslinked films prepared in 24 well plates (Corning) were seeded
with human dermal fibroblasts ( ×5 104) in phenol red free DMEM
(Invitrogen) with 10% FBS and 1% penicillin/streptomycin for 1, 3 and
7 days and placed in a 37 °C incubator with 5% CO2. Media was
changed every 2 days and frozen for cytotoxicity assays. At each time
point, MTS solution (Promega, CellTiter 96; 20 l per 100 l of media) was
added and the plate incubated for 2 h at 37 °C. 100 l of solution was
transferred to a 96 well plate (Corning) and the absorbance read at
490 nm using a SPECTROstar Nano plate reader (BMG LABTECH Ltd,
Aylesbury, UK). A standard curve with known cell numbers was used to
convert absorbance readings to cell number. Results are reported as
means ± standard deviations of three independent experiment per-
formed in triplicate.
2.9. LDH cell death assay
Spent media collected from the cell proliferation assay was spun
down at 300 rpm to remove any cells and 100 l pipetted into a 96 well-
plate (Corning). 100 l of LDH substrate (Roche) was added and colour
developed for 20 min at 37 °C. The absorbance was read at 490 nm
using a SPECTROstar Nano plate reader (BMG LABTECH Ltd,
Aylesbury, UK).
2.10. Live-dead cell imaging
The viability of fibroblasts seeded on crosslinked collagen films on
days 1, 4 and 7 was assessed using the LIVE/DEAD assay (Invitrogen).
Wells were washed with PBS (×3) and stained with 4 M calcein-AM
(LIVE) and 2 M ethidium homodimer-1 (DEAD) for 40 min at ambient
room temperature. Images were taken using a Zeiss Axio Observer Z1
microscope with an AxioCam 503 camera (10× objective lens; Carl
Zeiss Ltd, Cambridge, UK). The calcein-AM dye was detected using
excitation/emission set at 495 nm/515 nm and the nucleus staining
ethidium homodimer-1 dye detected at excitation/emission 495 nm/
635 nm. Brightness and contrast of each channel was then adjusted
prior to merging the image channels to minimise signal from auto-
fluorescent collagen fibres in the background.
2.11. Cell spreading imaging
2.11.1. Immunofluorescent staining
Crosslinked collagen plates (24 well) were pre-blocked with 800 l of
5% BSA (w/v; Sigma Aldrich) for 60 min at room temperature and
seeded with 5000 cells suspended in serum free DMEM media for 2 h at
37 °C. The plates were subsequently washed with PBS (×3) and fixed
with 3% glutaraldehyde (Sigma-Aldrich) for 20 min at room tempera-
ture. Plates were washed with PBS and permeabilised with 0.5% Triton-
X (Sigma-Aldrich) for 5 min. Cells were stained with Flash Phalloidin-
594 (Biolegend) for 40 min at room temperature, followed by staining
with DAPI (Sigma-Aldrich) for 2 min in water. Plates were imaged using
a Zeiss Axio Observer Z1 microscope with an AxioCam 503 camera
(20× and 40× objective lens; Carl Zeiss Ltd, Cambridge, UK).
2.11.2. Image processing
Images were subsequently processed and analysed using the Fiji
image processing package of ImageJ (NIH). A 100 pixel rolling ball
radius background subtraction was applied to the DAPI channel
(350 nm excitation/450 nm emission) and a 300 pixel rolling ball ra-
dius to the phalloidin channel (590 nm excitation/611 nm emission).
Brightness and contrast of each channel was then adjusted prior to
merging the image channels to minimise signal from autofluorescent
collagen fibres. Single cells were chosen and isolated using the colour
threshold in the phalloidin channel.
2.12. Collagen-I expression
Crosslinked films prepared in 24 well plates (Corning) were seeded
with human dermal fibroblasts ( ×5 104) in phenol red free DMEM
(Invitrogen) with 10% FBS and 1% penicillin/streptomycin and placed
in a 37 °C incubator with 5% CO2 for 7 days, with media replacement
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on Day 3. Media from the samples were extracted on Day 7 for an
MMP1 ELISA analysis.
Total RNA was extracted from human dermal fibroblasts using the
Mini Kit (Qiagen) and subjected to reverse transcription (using random
hexamers) followed by quantitative polymerase chain reaction (PCR).
The human Collagen-I alpha 1 gene on Chromosome 17 from exon 1 to
exon 49 was reannotated (included as part of the Open Data). Collagen
type I alpha chain forward and reverse primers were designed as 5′
CTGGCAGCAAAGGAGACAC 3’ (exon 20) and 5′ TCGCTTTCCTTCCTC
TCCAG 3’ (exon 21), respectively. A TaqMan fluorogenic probe (5′-
6FAM- ACCAACAGGGCCAGGCTCTCCC 3′) was designed for Col-I
alpha chain quantification, binding to the 3′ end of exon 20 and 5′ end
of exon 21. The probe contains a fluorescent reporter 6-carboxy-
fluorescein (FAM) at the 5′ end and a fluorescent quencher 6-carbox-
ytetramethylrhodamine (TAMRA) at the 3′ end. Real-time quantitative
PCR was performed on the cDNA of both the Collagen-I alpha chain and
as an internal control, the GAPDH gene(Thermofisher, Hs02786624_g1)
The reverse transcription reaction was performed using the reverse
primer and reverse transcriptase (TaqMan-compatible, ThermoFisher
N8080234). Real-time PCR was performed in duplex for the GAPDH
and Col-I primers and probe sets using TaqMan MasterMix
(ThermoFisher 4370048). The cycle threshold or Ct value, which cor-
relates inversely with the concentration of target mRNA, was de-
termined as the cycle number at which the fluorescence emission of the
reporter probe increases above a threshold level. The results from the
thermocycler (Applied Biosystems 7300) are reported as the mean
GAPDH normalised Ct for Col-I expression ± standard deviations of
three independent experiment performed in triplicate.
2.13. Human collagenase MMP-1 ELISA
The collected cell culture supernatants from the PCR experiment
were diluted 1:200 in media. The media was used to perform the
Human MMP1 ELISA kit (Abcam, ab215083) according to manufac-
turer's instructions for cell culture supernatants. Results are reported as
means ± standard deviations of three independent experiment per-
formed in triplicate.
2.14. Swelling measurements
Crosslinked collagen films were weighed then incubated in 5 mL
deionised water for 24 h at 37 °C. The hydrated samples were blotted on
filter paper, and the hydrated films were subsequently weighed. The









The 24 well plates with cells seeded for 7 days and lysed for PCR
were imaged using phase contrast microscopy to identify morphological
changes or the presence of shrinkage in the films following cell culture.
Images were taken using a Zeiss Axio Observer Z1 microscope with an
AxioCam 503 camera (10× objective lens; Carl Zeiss Ltd, Cambridge,
UK).
2.16. Statistical analysis
Unless otherwise stated =α 0.05 for all statistical analyses used. All
datasets were evaluated for normality and homoscedasticity using the
Anderson-Darling Normality and Levene's tests respectively. Where
datasets are noted to be normally distributed and homoscedastic, a one-
way ANOVA test was performed followed by a Tukey post-hoc test.
Where datasets do not pass the normality and homoscedasticity tests,
the Kruskall-Wallis non-parametric test and Mann-Whitney U post-hoc
test were employed. * indicates <p α. All statistical annotation in-
dicates the statistical difference between the data point annotated and
the non-crosslinked (NonXL) values. Individual p-values of each com-
parison can be obtained from the supplementary files in the Apollo data
repository containing raw data.
3. Results
3.1. Chemical and mechanical characterisation
The crosslinking conditions are represented with respect to a stan-
dard crosslinker solution concentration: the ‘100%’ standards for EDC-
NHS, genipin and TG2 are defined in the Materials and Methods
(Section 2). The results of the ninhydrin free amine assay, shown in
Fig. 1 reveal that with increasing crosslinker concentrations of EDC-
NHS and genipin, a greater degree of crosslinking was achieved. At the
lowest concentrations of genipin and EDC-NHS, approximately 20%
amine crosslinking was achieved. The highest concentrations of EDC-
NHS and genipin produced up to 52% and 35% of crosslinking re-
spectively. However, TG2 produced the same degree of amine reduction
for all enzyme concentrations tested (~50%). Representative FTIR
spectra and triple helical contents measured for the non-crosslinked,
EDC-NHS, genipin- and TG2 treated collagen films revealed no statis-
tically significant differences in the triple helical content of the protein,
indicating that minimal changes were imparted to the conformation of
the protein upon crosslinking (Supplementary Information).
The tensile modulus, strain to failure and ultimate tensile strength
of the collagen films were also measured to characterise the impact of
chemical crosslinking on the mechanical properties of the films (Fig. 2a,
b and 2c). Representative stress-strain curves are provided in the Sup-
plementary Information. The tensile test data revealed that there was a
significant increase in the tensile modulus upon crosslinking with all
conditions of EDC-NHS and genipin by up to 2000% and 400% re-
spectively at the highest concentrations. For the same degree of cross-
linking of approximately 20%, genipin offers a slightly higher stiffness
in comparison to its EDC-NHS counterpart. On the other hand, the
tensile modulus decreased by up to 80% upon crosslinking with TG2.
Furthermore, EDC-NHS and genipin-treated films withstood sig-
nificantly higher tensile stresses (by up to 400% and 130% respectively)
Fig. 1. Chemical characterisation of treated collagen films: The ninhydrin assay
was used to quantify the degree of collagen film crosslinking using EDC-NHS,
genipin and TG2. The percentages on the x-axis represent the concentrations of
crosslinking solutions, with the resulting degree of crosslinking (y-axis) de-
pending on the nature of the crosslinking reaction applied. Samples exhibiting a
significant difference from the non-crosslinked sample are noted with a *.
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when compared with the non-crosslinked samples. TG2 treated films
demonstrated no significant improvement in strength at low cross-
linking concentrations, and a significant 66% reduction in the failure
strength at the highest crosslinking concentrations (200%). With the
notable exception of TG2 treatment where up to a 140% increase was
observed in the strain to failure, all other conditions of treatment re-
sulted in a reduction of the strain at failure by up to 85%.
The effect of incubating films in Tris buffer at 37 °C for 24 h on the
mechanical properties was also evaluated as a control. A reduction in
modulus from the non-crosslinked film was noted for all concentrations
of TG2 crosslinking and Tris buffered films. Only the highest con-
centration of TG2 exhibited a significant reduction from the Tris buf-
fered samples. The TG2 crosslinked films for tensile testing also ex-
hibited significant shrinkage post crosslinking. This shrinkage was
observed when the collagen films were placed in pure Tris buffer at
37 °C but not in Type II de-ionised water at 37 °C.
3.2. Cell attachment and proliferation
Cellular adhesion via integrin receptors present on the surface of
human dermal fibroblasts to the GXOGER motif present on collagen
fibres was investigated. Here, fibroblasts were added to non-crosslinked
and EDC-NHS, genipin and TG2 treated collagen films in the presence of
either Mg2+ or EDTA. Values for total adhesion (Mg2+-dependent),
non-specific (EDTA) and specific (Mg2+−EDTA) are displayed in
Fig. 3a.
Data from EDC-NHS treated films revealed a statistically significant
increase in non-specific binding with increasing crosslinker concentra-
tions (50% and 100%) and a decrease in integrin specific binding. All
genipin crosslinked films, and 40% TG2 crosslinked films have a small
but statistically significant increase in non-specific binding in compar-
ison with non-crosslinked and ethanol crosslinked films. The overall,
integrin specific cell attachment remains largely unaffected across all
concentrations of genipin and TG2 crosslinked films when compared
with non-crosslinked control samples, consistent with an intact
GXOGER motif on the collagen fibres with these two crosslinkers.
The effects of crosslinking collagen using EDC-NHS, genipin and
TG2 on HDF proliferation were assessed using the MTS assay (Fig. 3b).
Over the seven-day period, no significant proliferation was observed
with the non-crosslinked collagen films. An increase was noted with the
Day 4 proliferation values of EDC-NHS crosslinked and genipin cross-
linked films, as well as the ethanol control when compared with un-
treated collagen films. The Day 4 proliferation values on TG2 films and
100% EDC-NHS crosslinked films were not significantly different from
the non-crosslinked condition. EDC-NHS films revealed a sharp de-
crease in the proliferation on Day 7, to a value significantly lower than
the cell numbers observed for non-crosslinked films. A similar decrease
was also seen with the ethanol controls at Day 7. Although there was no
Fig. 2. Mechanical characterisation of collagen films
crosslinked with EDC-NHS, genipin and TG2: a)
Tensile modulus b) Strain at failure and c) Tensile
failure. Subfigures (i) represent the data with respect
to the concentrations of various crosslinkers.
Samples exhibiting a significant difference from the
non-crosslinked sample are noted with a *, and from
the Tris buffered sample are marked with a ^. Values
outside brackets represent crosslinker concentration
whereas values in brackets represent the ‘degree of
crosslinking’ as determined by the ninhydrin free
amine assay for a given condition. Subfigures (ii)
summarise the data as a function of the ’degree of
crosslinking’.
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significant increase in the total or specific cell attachment with the TG2
treated samples, by day 7 a significant increase in proliferation was also
observed when compared with the non-crosslinked samples. Both the
untreated and treated films cast on the well-plates were stable over the
seven-day cell culture period and displayed negligible swelling or
shrinkage (Supplementary Information, Figs. 8 and 10).
The gene expression level of the ECM protein Collagen-I, by the
seeded human dermal fibroblasts was found to be unaffected by the
crosslinking of the substrates (Supplementary Information). The ex-
pression levels of matrix metalloproteinase-1 (MMP-1), a collagenase
that can degrade ECM proteins was noted to increase with increasing
concentrations of EDC-NHS and TG2-treatment (Supplementary
Information). Interestingly, this was not observed for genipin cross-
linking where MMP-1 levels were found to decrease with increasing
crosslinking concentration.
3.3. Cytotoxicity
To evaluate whether the decrease in cell number corresponded to
cell death from encountering a cytotoxic environment, an LDH assay
was performed on the supernatant medium from the MTS cell pro-
liferation assay. While some metabolic activity was noted with ethanol
treatment and crosslinking at Day 4 and 7, as seen in Fig. 4, cell death
was negligible for all conditions given the initial number of seeded
cells.
These observations were further supported by the use of the live/
dead assay. Fig. 5 shows fluorescence microscopy images from Day 7 of
the assay, where live cells appear green due to the retention of esterase
in intact cell membranes (positive control) and dead cells appear red
due to the infiltration of ethidium bromide-1 and staining of the DNA
though their damaged cell membranes (negative control) during
apoptosis. Little to no apoptotic cells were observed on any of the
crosslinked films over the course of 7 days, and nearly all cells were
viable on the differently treated films. Most notably, HDFs were able to
grow homogeneously on the 10% EDC-NHS crosslinked samples. Films
crosslinked with higher concentrations of EDC-NHS also contained all
live cells (in green), but were more sparsely colonised. For the genipin
treated films cells grow homogeneously and blanket the entire film at
all crosslinking conditions with live cells. For the TG2 treated films, less
live cell coverage of the films was observed at the lowest crosslinking
conditions, with homogeneous coverage of cells observed at the higher
crosslinking conditions. Overall, this assay confirmed that very low
levels of cell death was observed for any cells adhered onto the surface
of all films over a seven-day period (Supplementary Information, Figs. 4
and 5 for Day 1 and 4 images).
3.4. Cell spreading
A cell spreading study was conducted to characterise the mor-
phology of HDFs on non-crosslinked as well as EDC-NHS, genipin and
TG2 treated films as seen in Fig. 6.
Several qualitative differences in the cell morphology can be ob-
served between the treatments. For the EDC-NHS treated films, some
single cells were well-spread on the film surfaces, whereas others have
begun their apoptotic detachment from the sample surface. (Fig. 6c and
d). A greater incidence of such apoptotic cells lifting off in EDC-NHS
treated films was observed at the higher concentrations of EDC-NHS.
The spindle-like morphology of the filopodia as labelled in Fig. 7a were
observed in 50% and 100% EDC-NHS treated films. Such filopodia were
not noted in any other condition barring the lowest concentration of
TG2 (Fig. 6h).
For all other conditions of crosslinking, broad lamellipodia was
Fig. 3. Integrin mediated adhesion of human dermal fibroblasts and cellular
proliferation over 7 days in culture. (a) LDH attachment assay performed on
non-crosslinked and EDC-NHS, genipin and TG2 crosslinked films. Integrin-
specific and non-specific binding were separated through the addition of EDTA
or MgCl2 to cell media. (b) Cell proliferation over 7 days was evaluated using
the MTS assay. A * indicates p < 0.05 with respect to the non-crosslinked
condition whereas ^ indicates p < 0.05 with respect to the ethanol treated
conditions. Values outside brackets represent crosslinker concentration whereas
values in brackets represent the ‘degree of crosslinking’ as determined by the
ninhydrin free amine assay for a given condition.
Fig. 4. Cytotoxicity analysis of human dermal fibroblasts cultured on chemi-
cally crosslinked collagen films. (a) The supernatant of cells cultured on the
crosslinked films over a 7 day period was analysed using the LDH metabolic
activity assay. A * indicates p < 0.05 with respect to the non-crosslinked con-
dition whereas ^ indicates p < 0.05 with respect to the ethanol treated condi-
tions. Values outside brackets represent crosslinker concentration whereas va-
lues in brackets represent the ‘degree of crosslinking’ as determined by the
ninhydrin free amine assay for a given condition.
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observed on the cells, with some tethers extending from the periphery.
Genipin crosslinked collagen fibres exhibited autofluorescence in the
red [31] channel, allowing the collagen fibres on to which the cells
have adhered to also be observed. These strands of auto-fluorescing
collagen fibres labelled in Fig. 7b were observed in Fig. 6e, f, 6g.
Though very few dorsal stress fibres are observed on the fibroblasts,
ventral actin stress fibres are prominent in all HDF adhered to genipin
and TG2 treated films, as labelled in Fig. 7b.
The data obtained here were also quantified in terms of the area,
perimeter, aspect ratio, circularity and roundness of a single cell
(Details provided in Supplementary Information, Table 1).
4. Discussion
Among the cues responsible for guiding cell attachment, surface
biochemistry and mechanical properties represent two of the most
significant stimuli presented by the substrate. In this study, we attempt
to separate the effects of the ligands available and the mechanical
properties of the collagen based constructs by characterising the che-
mical and mechanical properties of the crosslinked films and evaluating
short-term and long-term effects of the treatments on human dermal
fibroblast attachment and proliferation.
4.1. Chemical and mechanical characterisation
The EDC-NHS, genipin and TG2-treated films were characterised
using the ninhydrin assay to characterise the changes to the free amines
in the underlying collagen structure. By colorimetrically analysing the
purple ‘Ruhemann's dye’ released in the process [30], the ninhydrin free
amine assays revealed that all treatments resulted a reduction in the
Fig. 5. Cell viability on the non-treated and crosslinked films assessed using the LIVE/DEAD assay. Fibroblasts grown on tissue culture plastic was used as a positive
control and fibroblasts treated for 20 min with 3% glutaraldehyde was used as a negative control. Red: EthD, green: Calcein. (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this article.)
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free amines in collagen.
Previous work on 100% EDC-NHS collagen films revealed that
tensile modulus increased nearly six fold upon crosslinking [32] when
measured using both a tensile and compression testing rig [33] for films
and scaffolds respectively. Although many mechanical properties have
been characterised including storage and loss moduli for collagen gels
crosslinked by genipin [23,34] or shear resistance for TG2 crosslinked
fibrils [35], there has been little work on the tensile modulus for TG2-
and genipin-treated insoluble collagen films. Here we note a five-fold
increase in the tensile modulus after crosslinking with EDC-NHS at the
lower end, and an improvement of nearly two orders of magnitude at
the higher end of the EDC-NHS treated films and over an order of
magnitude increase in modulus with genipin treated films (Fig. 2a).
Similarly, this work builds on previous comparisons of genipin and
EDC-NHS crosslinking of chitosan-collagen-elastin films [36] by nor-
malising the mechanical properties obtained as a function of the free
amines reduction or the ‘degree of crosslinking’. The tensile modulus
for genipin-treated samples is slightly higher than the EDC-NHS
equivalent at a given degree of crosslinking. However, the mechanical
stiffness range covered by genipin lies in the middle of the crosslinking
range offered by EDC-NHS. This presents genipin as a viable alternative
for EDC-NHS where similar mechanical properties are desired.
Fig. 6. Effect of crosslinking treatments on human dermal fibroblast morphology and spreading. Fibroblast morphology is imaged on non-crosslinked and EDC-NHS,
genipin- and TG2-treated collagen films. HDFs are observed to cluster and demonstrate a rounded morphology with increasing EDC-NHS crosslinking, expressing a
spindle-like morphology of the filopodia (labelled in Fig. 7a) on the 50% and 100% EDC-NHS treated films. HDFs present in all other conditions are well-spread
exhibiting broad lamellipodia. Fibroblasts on genipin and TG2-treated films also possess prominent ventral stress fibres (labelled in Fig. 7b). Genipin-treated films
autofluorescence of collagen fibres in the red channel. Red: Phalloidin (actin), blue: DAPI (nucleus). (For interpretation of the references to colour in this figure
legend, the reader is referred to the Web version of this article.)
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Additionally, in this work, the thickness of each tested film was mea-
sured using optical microscopy, enabling more accurate measurements
of mechanical properties to be made as compared with previous works
which use an average thickness for a given condition [32].
As first explored in the introduction, a reduction in free amines may
occur either through the formation of amide crosslinks or the amine
reduction may also occur via a conversion of glutamines to glutamates
for the TG2 treated samples. Although TG2 has been noted to increase
the modulus in freeze-dried neutralised soluble collagen samples [26],
this work demonstrates for the first time, the global mechanical prop-
erties of insoluble collagen films that have been treated with TG2. Here,
the modulus decreased at all concentrations of TG2 when compared
with the non-crosslinked condition. A characterisation of these films
using atomic force microscopy of TG2-treated films demonstrated that
locally, TG2 improved the mechanical properties of collagen at low
concentrations but not at 200% [37]. This is consistent with the de-
creased elastic modulus at very high TG2 concentrations observed in
this paper. The macroscopic mechanical behaviour observed here is
likely to arise predominantly from the effect of the Tris buffer, since a
similar reduction in modulus is also noted for the Tris buffered samples.
Collagen hydrolysis occurs at temperatures as low as 5 °C at pH values
above 4.5 over a 24 h period [38]. Some reduction in the modulus may
therefore be attributed to hydrolysis of collagen at pH 7.4 for 24 h at
37 °C. However, the Tris buffer may also have a part to play in the
pronounced reduction, with evidence in literature suggesting its ‘non-
innocent’ role as a buffer via the formation of adducts with reduced
collagen [39].
However, further reduction in modulus at higher concentrations of
TG2 is unexpected when compared with the soluble collagen counter-
parts which are used in collagen-based hydrogel networks. By taking
into account the reduction in free amines, this behaviour can be re-
solved through the hydrolytic pathway that can be adopted by TG2 in
the presence of few amines [40,41]. From the results obtained here, it
seems likely that the relative immobility of collagen in the final cast
film results in a conversion of glutamines to glutamates as opposed to
the selective amidation of the glutamines (Supplementary Information
), unlike the mobile fragments of collagen in solution. This is further
supported by previous evidence with microbial transglutaminase where
the extent of crosslinking has been shown to depend on the extent of
denaturation of collagen that takes place at high temperatures, allowing
for the active sites within collagen to be accessible to the transgluta-
minase [42]. In this study, the lack of significant denaturation, and the
fibrillar nature of the collagen further support the suggestion that
collagen in a fibrillar form is an unsuitable substrate for significant
crosslinking. As a result, we can conclude that three films of varying
characteristics were created: stiff films with reduced glutamates (EDC-
NHS), compliant films with some increase in glutamates (TG2) and stiff
films with no reduction in glutamates (genipin).
4.2. Integrin-specific attachment and fibroblast proliferation
From the HDF attachment assay, EDC-NHS crosslinking was noted
to significantly ablate integrin-specific motifs in collagen, resulting in a
reduced specific binding at high concentrations of EDC-NHS. This result
is consistent with other observations of integrin specificity with the
integrin I domain adhesion [21] and anchorage dependent cells such as
HT1080 human fibrosarcomas, human platelets [43] and rat glioma
(Rugli) cells [21,28].
Previous work on the integrin-mediating binding to genipin-cross-
linked constructs have suggested a decrease in integrin-binding since
genipin may crosslink to arginines, resulting in the loss of RGD motifs
[44]. In this work, although genipin resulted in some significant non-
specific binding, the scale of this effect is much lower than its specific
binding, and the non-specific binding of EDC-NHS treated films. The
differences between the behaviours can be reconciled by the cryptic
nature of RGD motifs in triple helical collagen-I, where GXOGER serves
as the primary MIDAS motif for integrin-mediated binding [45]. Thus,
the integrin-specific binding through GXOGER motifs can be concluded
to be unaffected by genipin crosslinking in this work.
TG2-treatment of soluble collagen-I also did not result in any
changes to integrin specific binding. Therefore, although it was hy-
pothesised that an increase in glutamates may increase integrin specific
binding, this result suggests that the number of glutamates created are
either insignificant in their total number, or do not present a significant
contribution to the initial short-term attachment of fibroblasts. In the
TG2-crosslinked collagen constructs evaluated in the literature, β in-
tegrin expression has been reported to be increased after treatment
[17]. In these scaffolds however, the result is expected to arise from the
presence of TG2 in the scaffolds, in addition to the changes imparted by
TG2 to the collagen structure [17].
In addition to the glutamic acid residue of the MIDAS motifs, the
accessibility of the integrins has also been shown to be affected by steric
hindrance surrounding the integrin motifs in triple helix-mimicking
proteins [46]. While any crosslinks formed by TG2 and EDC-NHS are
‘zero-length’, genipin is incorporated into the collagen crosslinks. As
seen in Fig. 3a, though the inclusion of a large molecule such as genipin
Fig. 7. Labelled morphological features observed in attached human dermal fibroblasts in Fig. 6 a) filopodia (white arrows) extending from the cells to the substrate
in EDC-NHS crosslinked samples b) ventral stress fibres (blue arrows) visible on the genipin and TG2 crosslinked films. White scale bar on images corresponds to
10 m. Fibres of genipin crosslinked collagen also auto-fluoresce (green arrow) in the phalloidin channel. (For interpretation of the references to colour in this figure
legend, the reader is referred to the Web version of this article.)
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does not appear to affect the accessibility of the integrin sites, and the
treatment with TG2 also leaves the integrin sites unaffected as com-
pared with the non-crosslinked Collagen-I control.
The long-term effects of the availability of ligands and the me-
chanical properties of a film were further investigated through the MTS
cell proliferation assay (Fig. 3b). The comparison of the behaviour of
ethanol treated and EDC-NHS crosslinked samples suggests that there is
a delayed effect of the ethanol on the collagen films and consequently
the cells. The additional impact of reduced specific binding may also
explain the further reduction in proliferating cells at 100% EDC-NHS at
Day 4 and 7. Ethanol has previously been used to create esterification in
collagen [47]. The esterification was noted to improve cell activity and
survival of the pancreatic cells tested, much akin to the short term re-
sponse observed from Day 1–4 with the ethanol controls. Since ester-
ification requires the use of the carboxylic acids (E and D) in the col-
lagen, the lowered proliferation effect can be associated with the lack of
availability of suitable ligands for integrin specific binding over the
seven-day period.
This behaviour is also consistent with the increase in proliferation
seen with TG2 over the untreated samples, due to the increased glu-
tamates available upon TG2 treatment. As a result, the long-term pro-
liferation can be concluded to be dependent primarily on the avail-
ability of appropriate ligands, even if short-term proliferation may be
affected by mechanical stiffness as evidenced by the high rates of pro-
liferation from Day 1–4 for genipin and EDC-NHS crosslinked samples.
Although this study characterised the proliferation of HDFs on
crosslinked surfaces, there is further scope to investigate whether the
observed behaviour arises from a direct interaction with the crosslinked
collagen, or an indirect interaction through the ECM deposited on the
treated surface. It is hypothesised that at Day 1, cells interact directly
with the crosslinked films, but begin to deposit their own extracellular
matrix by Day 4. In normal human wound healing, the cell attachment
protein fibronectin can be detected histologically at Day 4, with col-
lagen-I and collagen-IV detected at Day 7 [48].
In this work, the data from Day 7 revealed no difference in the gene
expression levels of collagen I production by fibroblasts on the cross-
linked films (Supplementary Fig. 6), indicating that fibroblast function
was normal. However, an increase in the levels of MMP-1, a protease is
involved in the degradation of collagen was detected for the EDC-NHS
and TG2-treated substrates (Supplementary Fig. 7a). Increase in MMP-1
production has been found to be well-correlated with the effect of strain
experienced by the human dermal fibroblasts [49] and the stiffness of
the substrates [50]. MMP-1 levels can also be affected by the type of
ECM protein [51], and the type of substrate material, independently
from the substrate stiffness [52]. As a result, the increase in MMP-1
levels observed here may arise from the deviation from an ideal matrix
stiffness, differences in the deposition of other ECM proteins, or changes
to underlying chemical structure of collagen. Interestingly, the increase
in MMP-1 levels with TG2-treatment observed in this work is also
heavily contrasted with the decrease in MMP-1 levels observed with
TG2-crosslinked soluble collagen scaffolds in the literature [26], which
may arise either due to the lack of residual TG2 in our collagen films, or
due to the differences in chemical crosslinking by TG2 in soluble and
insoluble collagen. An in-depth investigation of ECM deposition and
remodelling is outside the aims and direct scope of this study and
provides a further avenue of exploration.
4.3. Cytotoxicity of crosslinking treatments
The cytotoxicity of the treatments was evaluated using the live/
dead stain and LDH assay on the supernatants of the MTS proliferation
assay. As seen from the representative images in Fig. 5, the viability of
fibroblasts is not affected by the ethanol, EDC-NHS, genipin or TG2
treatments. As seen in Fig. 4, there were few non-adherent cells on the
surface of all treated films. The extent of cell death across the seven-day
period also mirrors the trends seen with the proliferation seen in
Fig. 3b. However, the cell numbers in the LDH assay were over an order
of magnitude lower than the total seeded density on all films. This
suggests that though the treatments can affect cell death of non-ad-
herent cells, the overall cytotoxicity of the treatments is negligible.
The increase in cell proliferation, with little apoptosis observed with
the stiffened treated films has been previously noted with fibroblasts in
crosslinked substrates of tunable mechanical properties [53,54]. Al-
though the cellular attachment and proliferation results presented here
pertain to thin insoluble collagen films cast which are immobilised on
well plates and therefore are expected to show limited swelling (Sup-
plementary Information, Figs. 8 and 10) and cell infiltration, a com-
parison of 2D and 3D behaviour on gelatin constructs revealed that
similar trends were observed in two dimensional hydrogel films but not
in three dimensional hydrogel matrices [55].
4.4. Fibroblast spreading and morphology
The lack of variation in the overall cell spreading behaviour, ex-
cepting the greater incidences of rounded cells and cellular projections
at higher crosslinking concentrations of EDC-NHS, indicates that the
contact behaviour of the cells are largely dependent on the availability
of ligands on a substrate. This is akin to the behaviour seen when
human gingivial fibroblasts are seeded on fibrillar collagen with loca-
lised integrins [56]. The presence of filopodia has also been suggested
to be driven by the matrix compliance where the ability to form larger
focal adhesions and lamellipodia is reduced [57]. Therefore, the ex-
tension of long and thin filopodia at the highest levels of EDC-NHS
crosslinking is consistent with the simultaneous decrease in available
integrin specific cell binding sites (Fig. 3a), and an increase in substrate
rigidity (Fig. 2a).
4.5. Proposed mechanism of action
As a result, we propose the mechanism shown in Fig. 8 for human
dermal fibroblast attachment and proliferation. Human dermal fibro-
blasts begin spreading along the collagen surface, forming cell projec-
tions with specific binding sites on the film. In collagen substrates
where there is insufficient specific binding sites available for further
cell attachment, such as the EDC-NHS treated films, cell-cell junctions
are preferentially formed. Cell clusters formed on these surfaces begin
their apoptotic cycle, until they lift off the surface of the film, into the
supernatant as seen in Fig. 4. Conversely, fibroblasts strongly anchored
onto the collagen surface begin proliferating in response to the stiffness
of the substrate.
5. Conclusions
In this body of work, collagen constructs were crosslinked using
EDC-NHS, genipin and tissue transglutaminase to explore three ele-
ments of the collagen crosslinking process. EDC-NHS results in an ex-
tremely high tensile modulus, at the expense of integrin-specific at-
tachment and long-term cell proliferation through the loss of
glutamates in the crosslinking process.
At the same degree of crosslinking, genipin-treated films offer re-
markably high cell activity, and a comparable tensile modulus with
EDC-NHS treated films. Following this work, genipin therefore stands
out in its potential to replace EDC-NHS where medium to high me-
chanical stiffness and excellent cell attachment and proliferation are
desired. Tissue transglutaminase may promote the conversion of pre-
existing crosslinks in insoluble collagen to glutamines at high con-
centrations, resulting in low stiffness substrates that maintain higher
cell attachment and proliferation than untreated samples. The use of
three different crosslinking chemistries bring to light the relative im-
portance of mechanical and biochemical cues on human dermal fibro-
blasts. Although short-term proliferation may be driven by mechanical
cues, long-term stable proliferation of HDFs are correlated with high
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levels of integrin-specific binding, irrespective of the modulus post-
treatment.
The crosslinking process therefore represents a pathway for access
to different regimes within the property space of tensile modulus as
well as cell attachment and proliferation. As a result, the potential to
create structures of tunable mechanics and bioactivity in collagen can
be exclusively facilitated through the choice of crosslinker chemistry,
further expanding the versatility of collagen within tissue-engineering
scaffolds.
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